Treatment Options for Menstrual Migraines
For menstrual migraines, perimenstrual preventive treatment with a long-acting NSAID (like naproxen) or triptan (like frovatriptan or naratriptan) for 5 days, beginning 2 days before expected menstruation, is the recommended approach when acute treatment alone is insufficient. 1
Understanding Menstrual Migraine
- Approximately 8% of women with migraine experience attacks exclusively related to menstruation (pure menstrual migraine), while a larger percentage experience menstrually-related migraines that occur both during menstruation and at other times 1, 2
- Menstrual migraines are typically more severe, longer-lasting, and more resistant to treatment than non-menstrual migraines 2, 3
- These migraines are triggered by estrogen withdrawal that occurs before menstruation 4, 5
Treatment Approach
Acute Treatment Options
First-line medications:
Second-line medications:
Adjunct medications:
- Prokinetic antiemetics (domperidone, metoclopramide) for associated nausea/vomiting 1
Medications to avoid:
Preventive Treatment Strategies
Perimenstrual prophylaxis (short-term prevention):
- Long-acting NSAID (e.g., naproxen) taken daily for 5 days, beginning 2 days before expected menstruation 1
- Long-acting triptan (e.g., frovatriptan 2.5mg twice daily or naratriptan 1mg twice daily) following the same schedule 1, 6, 3
- This approach is particularly useful for women with pure menstrual migraine 1
Hormonal options:
- Some women with pure menstrual migraine without aura benefit from continuous use (without a break) of combined hormonal contraceptives 1
- IMPORTANT: Combined hormonal contraceptives are contraindicated in women with migraine with aura due to increased stroke risk 1, 5
- Transcutaneous estradiol 1.5mg has shown efficacy for short-term prophylaxis 3
Standard preventive medications (if menstrual migraines are part of frequent migraines throughout the month):
- First-line options: Beta-blockers (propranolol, metoprolol), candesartan, topiramate 1
- Second-line options: Amitriptyline, flunarizine 1
- Third-line options: OnabotulinumtoxinA, CGRP antagonists (erenumab, fremanezumab, eptinezumab) 1
- Note: Sodium valproate is absolutely contraindicated in women of childbearing potential 1
Monitoring and Follow-up
- Evaluate treatment response within 2-3 months after initiation or change in treatment 1
- Use headache calendars to track attack frequency, severity, and medication use 1
- Consider the Migraine Treatment Optimization Questionnaire (mTOQ-4) to evaluate effectiveness of acute medications 1
- If one preventive treatment fails, try another drug class as failure of one does not predict failure of others 1
Special Considerations
- For women who also require contraception, consider contraceptive strategies that can simultaneously address menstrual migraine 3
- Be aware that some antiepileptic medications used for migraine prevention can affect the efficacy of oral contraceptives 2
- Topiramate has minimal effect on oral contraceptives at doses below 200 mg/day 2
Treatment Algorithm
- Start with optimized acute treatment (NSAIDs first, then triptans if needed)
- If menstrual migraines persist despite optimal acute treatment, add perimenstrual prophylaxis
- For women with pure menstrual migraine without aura who need contraception, consider continuous combined hormonal contraceptives
- For women with frequent migraines throughout the month, consider standard preventive medications
- Regularly assess treatment effectiveness and adjust as needed